Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Study Suggests Proton Pump Inhibitors are Harmful for Breast Cancer Survivors

Proton pump inhibitors like Nexium, Prilosec, and PrevAcid  may not be the best choice for breast cancer patients, according to a study that suggests the medications could worsen cognitive decline among survivors. Many Breast Cancer Patients Already Experience Cognitive Decline … Continue reading

Belviq Weight Loss Drug Withdrawn from Market Due to Cancer Risk

Esai Co. is removing Belviq and Belviq XR from the market, after a clinical trial suggested the weight loss medications are associated with an increased risk of cancer. “As noted in a new Drug Safety Communication issued today, patients should … Continue reading

JPML Declines to Centralize Hotel Sex Trafficking Lawsuits

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has declined to centralize all federally filed hotel sex trafficking lawsuits before a single judge in one U.S. District Court. However, the decision does not mean the end of the litigation, as … Continue reading

Bayer Might End Private Sales of Monsanto Roundup

Bayer AG is reportedly considering a plan to end private sales of Roundup herbicide. According to Reuters, the proposal is part of ongoing settlement talks to resolve thousands of Monsanto Roundup lawsuits that blame the glyphosate-based weed killer for causing … Continue reading

Breast Implant Cancer Lawsuits Rise, With 6 New Filings in New Jersey Superior Court

Six women from around the United States are suing Allergan, Inc. over textured breast implants allegedly linked to a rare form of cancer. Do Biocell Textured Implants Increase Risk for Cancer? According to separate complaints filed in New Jersey Superior … Continue reading

More than 139,000 U.S. Military Veterans Pursuing 3M Combat Arms Earplugs Lawsuits

Millions of military veterans across the United States suffer from service-related hearing loss and tinnitus, including tens of thousands who blame dual-ended earplugs supplied by the 3M Company for their torment. “I Feel Like I am Being a Burden on … Continue reading

Wisconsin Firefighter Foam Restrictions Signed into Law

The Governor of Wisconsin has signed a new law restricting the use of firefighter foams that contain potentially dangerous chemicals called polyfluoroalkyl substances (PFAS). The law, which was signed by Governor Tony Evers on February 6th, prohibits the use of … Continue reading

Monsanto Roundup Lawsuits “Significantly” Closer to Settlement, Federal Bellwether Trial Postponed

A federal judge has agreed to suspend proceedings for an upcoming Monsanto Roundup trial, sparking even more speculation that the massive litigation involving the glyphosate-based herbicide is “significantly” closer to settlement. Roundup Lawsuit Deadlines Supsended for 28 Days Ken Feinberg, … Continue reading

Zantac Recall Takes $186 Million Bite Out of Sanofi Profits

Sanofi is feeling the effects of last year’s massive Zantac recall – especially on its bottom line. According to the French drug maker’s most recent earnings report, U.S. sales at its consumer health division dove nearly 13% during the fourth … Continue reading

New Research Appears to Confirm Injectafer Side Effects Concerns

Results of two new clinical trials appear to confirm concerns surrounding Injectafer side effects, especially a link to dangerously low phosphorous levels. Injectafer: Background Injectafer is an intravenous medication used to treat people suffering from iron-deficiency anemia who can’t tolerate … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content